Vertex Pharmaceuticals (VRTX) Non Operating Interest Expenses (2009 - 2025)
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Non Operating Interest Expenses (2009 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.68 Bn | 131.82 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.68 Bn | 77.68 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.67 Bn | 58.48 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.02 Bn | 51.88 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.83 Bn | 43.83 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.97 Bn | 34.87 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.23 Bn | 31.93 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.56 Bn | 27.72 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 582,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 7.50 Mn |
| Jun 30, 2024 | 9.90 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 10.60 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Dec 31, 2020 | 16.29 Mn |
| Sep 30, 2020 | 13.86 Mn |
| Jun 30, 2020 | 13.87 Mn |
| Mar 31, 2020 | 14.14 Mn |
| Dec 31, 2019 | 14.25 Mn |
| Sep 30, 2019 | 14.55 Mn |
| Jun 30, 2019 | 14.84 Mn |
| Mar 31, 2019 | 14.87 Mn |
| Dec 31, 2018 | 18.74 Mn |